It has been shown that monocytes from T2DM patients display vascular endothelial growth factor (VEGF)A impaired function,6 since they show a reduced migratory response towards VEGFA and placental growth factor (PlGF)‐1, earlier described as VEGFA resistance.6, 7. The gene discussed is VEGFA; the disease is type 2 diabetes mellitus.